Prostatic Hyperplasia: all 803 studies

Page 3 of 9. Open to participants first (174), then studies with results posted, then the rest; newest registration first within each.

• Rezum I Pilot Study for Benign Prostatic HyperplasiaCompletedNCT02943070Not applicableResults posted
• Rezum FIM Optimization StudyCompletedNCT02940392Not applicableResults posted
• Prostate Artery Embolization (PAE) for Lower Urinary Tract Symptoms (LUTS) Due to Benign Prostatic Hyperplasia (BPH)CompletedNCT02930889Not applicableResults posted
• Benign Prostatic Hyperplasia (BPH) Screening Tool Case Finding Study in Subjects >=50 YearsCompletedNCT02757963Phase 4Results posted
• A Study to Evaluate the Efficacy, Safety, and Tolerability of Mirabegron in Men With OAB Symptoms While Taking Tamsulosin Hydrochloride for Lower Urinary Tract Symptoms (LUTS) Due to Benign Prostatic Hyperplasia (BPH)CompletedNCT02757768Phase 4Results posted
• A Phase 4 Study to Evaluate the Efficacy, Safety, and Tolerability of Mirabegron in Male Subjects With Overactive Bladder (OAB) Symptoms, While Taking the Alpha Blocker for Benign Prostatic Hypertrophy (BPH)CompletedNCT02656173Phase 4Results posted
• Study of Median Lobe Prostatic UroLift ProcedureCompletedNCT02625545Not applicableResults posted
• Pivotal Study to Assess the Safety and Effectiveness of the iTind DeviceCompletedNCT02506465Not applicableResults posted
• Waterjet Ablation Therapy for Endoscopic Resection of Prostate Tissue (WATER)CompletedNCT02505919Not applicableResults posted
• A Study of Tadalafil (LY450190) in Participants With Lower Urinary Tract Symptoms (LUTS) Suggestive of Benign Prostatic Hyperplasia LUTS (BPH-LUTS).CompletedNCT02431754Phase 4Results posted
• Determine the Bioequivalence of Two Formulations of Tamsulosin HCl Capsules in Fed Male.CompletedNCT02417844Phase 1Results posted
• Determine the Bioequivalence of Two Formulations of Tamsulosin HCl Capsules in Fasted Male.CompletedNCT02417831Phase 1Results posted
• Prostate Artery Embolization as a Treatment for Benign Prostatic Hyperplasia in Men With Prostates Larger Than 90 GramsTerminatedNCT02396420Phase 2Results posted
• Research on Benefit of Umooze as Add- on Therapy in Benign Prostatic HyperplasiaCompletedNCT02313233Not applicableResults posted
• Randomized Controlled Trial Comparing Two Different Morcellators for HoLEP ProceduresCompletedNCT02195622Not applicableResults posted
• GreenLight XPS Laser System Retrospective Chart ReviewCompletedNCT02139969Results posted
• Study to Compare the Efficacy and Safety of Combination Treatment With Dutasteride and Tamsulosin With Tamsulosin Monotherapy, in Men With Moderate to Severe Benign Prostatic HyperplasiaCompletedNCT02058368Phase 3Results posted
• Prostatic Artery Embolization (PAE) for Treatment of Benign Prostatic Hyperplasia (BPH)CompletedNCT02026908Not applicableResults posted
• A Study of Tadalafil in Men With Benign Prostatic Hyperplasia (BPH) and Erectile Dysfunction (ED)CompletedNCT01937871Phase 3Results posted
• Prostate Embolization for Benign Prostatic HyperplasiaCompletedNCT01924988Phase 1/2Results posted
• Safety and Efficacy Study for the Treatment of BPH (Enlarged Prostate)CompletedNCT01912339Not applicableResults posted
• UroLift System TOlerability and ReCovery When Administering Local AnesthesiaCompletedNCT01876706Not applicableResults posted
• Prostate Artery Embolization With Embosphere Microspheres Compared to TURP for Benign Prostatic HyperplasiaTerminatedNCT01789840Not applicableResults posted
• Prospective Sexual Function Study for BPH SubjectsCompletedNCT01777269Phase 4Results posted
• Clinical Trial of Safety and Efficacy of Afalaza in Patients With Symptoms of Benign Prostatic Hyperplasia and Risk of ProgressionCompletedNCT01716104Phase 3Results posted
• Cyclooxygenase-2 (COX-2) Inhibitor Reduces Serum Prostatic Specific Antigen (PSA) LevelsCompletedNCT01678313Phase 2Results posted
• Safety and Efficacy of 0.5mg Dutasteride and 0.4mg Tamsulosin Combination Once Daily for Six Months for Benign Prostatic HyperplasiaTerminatedNCT01673490Phase 4Results posted
• Effect of Deep BLock on Intraoperative Surgical ConditionsCompletedNCT01631149Phase 4Results posted
• Effectiveness of onaBoNT-A vs Oral Tamsulosin in Men With BPH and LUTSCompletedNCT01589263Phase 2Results posted
• Comparison of Finasteride and Tamsulosin for Treatment of Benign Prostatic Hyperplasia (BPH) (MK-0906A-149 AM2)TerminatedNCT01534351Phase 3Results posted
• BPH-6: Comparison of the UroLift System to TURP for Benign Prostatic HyperplasiaCompletedNCT01533038Not applicableResults posted
• Phase 4 Study of Greenlight XPS Laser Versus BiVAP Saline Vaporization of the Prostate in Men With Symptomatic Benign Prostatic HyperplasiaCompletedNCT01500057Phase 4Results posted
• Phase 3 Study of Tadalafil Once-Daily in Asian Men With Benign Prostatic Hyperplasia (BPH)CompletedNCT01460342Phase 3Results posted
• Establishing Predictors of Enlarged Prostate Treatment Adherence: Linking Symptom Improvement to AdherenceCompletedNCT01390870Results posted
• Clinical and Economic Outcomes of Patients Utilizing Combination Therapy for Enlarged Prostates: A Henry Ford Database AssessmentCompletedNCT01386983Results posted
• Demonstrating the Clinical and Economic Benefit of 5 Alpha Reductase Inhibitor Adherence in Benign Prostatic HyperplasiaCompletedNCT01334723Results posted
• Evaluating the Impact of Early Versus Delayed 5 Alpha Reductase Inhibitor Treatment on the Risk of Emergent Surgery in Men With Benign Prostatic HyperplasiaCompletedNCT01332487Results posted
• Dutasteride in Enlarged Prostate Economic Assessment: A Retrospective Database Pooled Analysis of Early 5-alpha Reductase Inhibitor UseCompletedNCT01332435Results posted
• SECOTEX® (Tamsulosin Hydrochloride) Bioequivalence Study Brazil - Fed AdminCompletedNCT01330303Phase 1Results posted
• Benign Prostatic Hypertrophy Treatment Patterns & Outcomes: MarketscanCompletedNCT01323998Results posted
• AVODART(Dutasteride) Post-marketing Surveillance(PMS)CompletedNCT01299571Results posted
• Comparative Efficacy of Dutasteride Plus Tamulosin With Lifestyle Advice Versus Watchful Waiting Plus Lifestyle Advice in the Management of Treatment naïve Men With Moderately Symptomatic Benign Prostatic Hyperplasia and Prostate EnlargementCompletedNCT01294592Phase 4Results posted
• The Safety and Effectiveness of UroLift: LIFT Pivotal StudyCompletedNCT01294150Not applicableResults posted
• SECOTEX® (Tamsulosin Hydrochloride) Bioequivalence Study Brazil - Fast AdminCompletedNCT01262989Phase 1Results posted
• Photoselective Vaporization of the Prostate With the GreenLight XPS™ Laser System vs TURP for the Treatment of BPHCompletedNCT01218672Not applicableResults posted
• An Efficacy Trial of Electroacupuncture at Points of Bilateral BL33 for Mild and Moderate Benign Prostatic HyperplasiaCompletedNCT01218243Phase 2Results posted
• A Study of Tadalafil in Benign Prostatic HyperplasiaCompletedNCT01183650Phase 1Results posted
• A Study in Benign Prostatic HyperplasiaCompletedNCT01152190Phase 3Results posted
• A Study of Tadalafil Use With Finasteride in Men With Enlarged Prostates and Urinary SymptomsCompletedNCT01139762Phase 3Results posted
• Safety and Efficacy of Botulinum Toxin Type A to Treat Lower Urinary Tract Symptoms Due to Benign Prostatic HyperplasiaCompletedNCT01107392Phase 2Results posted
• A Study in Men With Benign Prostatic HyperplasiaTerminatedNCT01097707Phase 2Results posted
• Long Term Study of Solifenacin Succinate and Tamsulosin Hydrochloride Oral Controlled Absorption System (OCAS) in Males With Lower Urinary Tract SymptomsCompletedNCT01021332Phase 3Results posted
• Study of Solifenacin Succinate and Tamsulosin Hydrochloride OCAS in Males With Lower Urinary Tract SymptomsCompletedNCT01018511Phase 3Results posted
• A Post Marketing Surveillance Study Of Doxazosin Mesylate GITS Among Filipino Patients With Benign Prostatic Hyperplasia (BPH)CompletedNCT01003886Results posted
• A Study of Tadalafil in Men With Benign Prostatic HyperplasiaCompletedNCT00970632Phase 3Results posted
• Efficacy and Safety of S-Equol on Men With Benign Prostatic HyperplasiaCompletedNCT00962390Phase 2Results posted
• A Trial of Degarelix in Men With Lower Urinary Tract Symptoms (LUTS) Associated With Benign Prostatic Hyperplasia (BPH)CompletedNCT00947882Phase 2Results posted
• Dutasteride With Tolterodine ER or Placebo to Treat Lower Urinary Tract Symptoms (LUTS)CompletedNCT00939120Phase 4Results posted
• A Study Evaluating the Effect of Botulinum Toxin Type A on Semen Quality in Patients With Benign Prostatic HyperplasiaCompletedNCT00894517Phase 1/2Results posted
• Transperineal Intraprostatic Injection of PRX302 Under Ultrasound Guidance for Management of Prostatic HyperplasiaCompletedNCT00889707Phase 2Results posted
• Multinational Study to Evaluate Tadalafil in Asian Men With Signs and Symptoms of Benign Prostatic HyperplasiaCompletedNCT00861757Phase 3Results posted
• A Study in the Treatment of Erectile Dysfunction and Benign Prostate HyperplasiaCompletedNCT00855582Phase 3Results posted
• A Study of Tadalafil in Men With Benign Prostatic Hyperplasia Symptoms Who Are Being Treated With Alpha BlockersCompletedNCT00848081Phase 3Results posted
• Study to Treat Patients Who Have Signs and Symptoms of Benign Prostatic Hyperplasia (BPH) With Tadalafil DailyCompletedNCT00827242Phase 3Results posted
• A Study of Silodosin 8 mg Daily for the Treatment of Nocturia in Men With Benign Prostatic HyperplasiaCompletedNCT00793819Phase 2Results posted
• Study of Tadalafil Once-a-Day for 12 Weeks in Japanese Men With Benign Prostatic Hyperplasia Followed by an Open-Label ExtensionCompletedNCT00783094Phase 2Results posted
• MRI and Magnetic Resonance Spectroscopy Imaging in Patients Receiving Dutasteride for Benign Prostatic Hypertrophy and Low-Risk Prostate CancerCompletedNCT00706966Not applicableResults posted
• Dutasteride and Flex Dose of Tamsulosin on as Needed Basis, to Treat Benign Prostatic HyperplasiaCompletedNCT00701779Phase 4Results posted
• Cetrorelix Pamoate IM Regimens in Patients With Symptomatic Benign Prostatic Hyperplasia (BPH)CompletedNCT00670306Phase 3Results posted
• Cetrorelix Pamoate in Patients With Symptomatic Benign Prostatic Hypertrophy (BPH)CompletedNCT00663858Phase 3Results posted
• Study of Polyphenon E in Men With High-grade Prostatic Intraepithelial NeoplasiaCompletedNCT00596011Phase 2Results posted
• Pilot Study Investigating Safety and Efficacy of Tadalafil as Treatment for Benign Prostatic Hyperplasia (BPH) in Asian MenCompletedNCT00540124Phase 2Results posted
• Dutasteride 0.5mg For The Treatment Of Chinese Patients With Benign Prostatic Hyperplasia (BPH)CompletedNCT00527605Phase 3Results posted
• Explorative Study of Degarelix for Treatment of Benign Prostatic Hyperplasia.CompletedNCT00527488Phase 2Results posted
• 5-Alpha Reductase and Anabolic Effects of TestosteroneCompletedNCT00475501Phase 2Results posted
• A Long-Term Study Examining the Treatment of Benign Prostatic Hyperplasia With Photoselective VaporizationCompletedNCT00465101Phase 4Results posted
• Vardenafil in Greenlight(TM) Laser Surgery of Benign Prostate HypertrophyCompletedNCT00461123Phase 2Results posted
• Botulinum Toxin Injection for the Management of BPHCompletedNCT00451191Phase 2Results posted
• Cetrorelix (CET) Pamoate Regimens in Patients With Symptomatic Benign Prostatic Hypertrophy (BPH)TerminatedNCT00449150Phase 3Results posted
• A Clinical Trial Comparing Laser TURP With and Without Dutasteride.TerminatedNCT00431626Phase 3Results posted
• Effects of Tadalafil Once a Day for 12 Weeks in Men With Signs and Symptoms of Benign Prostatic HyperplasiaCompletedNCT00386009Phase 2Results posted
• Study of Tadalafil Once-a Day for 12 Weeks in Men With Signs and Symptoms of Benign Prostatic HyperplasiaCompletedNCT00384930Phase 2/3Results posted
• Dutasteride (GI198745) In Benign Prostatic Hyperplasia SubjectsCompletedNCT00368979Phase 3Results posted
• Safety and Efficacy Study of Botulinum Toxin Type A to Treat Lower Urinary Symptoms Due to Benign Prostatic HyperplasiaCompletedNCT00284518Phase 2Results posted
• The Evaluation of the Safety of a New Drug for Benign Prostatic Hyperplasia Used for 9 MonthsCompletedNCT00224133Phase 3Results posted
• A New Drug for Benign Prostatic Hyperplasia (BPH) Compared With PlaceboCompletedNCT00224120Phase 3Results posted
• A New Drug for Benign Prostatic Hyperplasia (BPH) Compared With PlaceboCompletedNCT00224107Phase 3Results posted
• TRADE-Testosterone Replacement and Dutasteride EffectivenessCompletedNCT00194675Phase 4Results posted
• Benign Prostatic Hyperplasia Trial With Dutasteride And Tamsulosin Combination TreatmentCompletedNCT00090103Phase 3Results posted
• Optimization of Surgical Treatment Pathways for BPH Based on Real-World DataCompletedNCT07872085Not applicable
• Suprapubic Cystostomy as an Adjunct to Monopolar Transurethral Enucleation of the ProstateCompletedNCT07841964Not applicable
• Standard Versus Double Alpha Blockers Treatment for Symptomatic Benign Prostatic ObstructionActive, not recruitingNCT07815379Phase 4
• Ejaculation-Preserving Versus Conventional Dual Wavelength Diode Laser Vaporization of the ProstateCompletedNCT07777068Not applicable
• Efficacy and Safety of Modified Prostatic Urethral Lift (mPUL-ZA) for Benign Prostatic HyperplasiaCompletedNCT07776158Not applicable
• Spinal Versus General Anesthesia on Coagulation and Fibrinolysis During Transurethral Resection of the ProstateCompletedNCT07734233Not applicable
• Bipolar Enucleation of the Prostate Versus Bipolar TURPCompletedNCT07718256Not applicable
• Effect of Different Dosing Regimens of Tadalafil or Tamsulosin Combined With 5α-Reductase Inhibitors on Urinary and Sexual Outcomes in Benign Prostatic HyperplasiaCompletedNCT07715448Phase 4
• ExMI vs. Biofeedback PFMT for Post-Prostatectomy IncontinenceActive, not recruitingNCT07698028Not applicable
• Conventional Fluid Management Versus Plethysmography Variability Index-based Goal-directed Fluid Management in Patients Undergoing Transurethral Resection of the ProstateActive, not recruitingNCT07669337Not applicable
• BOTOX Injection Technique for LUTS Due to BPHCompletedNCT07645456Phase 1

← Prostatic Hyperplasia overview